Dr. Salman Bhai

Salman Bhai, M.D., is an Assistant Professor in the Department of Neurology at UT Southwestern Medical Center and the Director of the Neuromuscular Center in the Institute of Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas. He specializes in neuromuscular disorders, particularly muscle disorders.Dr. Bhai earned his medical degree at Harvard University. He completed a residency in neurology at Brigham and Women’s Hospital and Massachusetts General Hospital, where he also received advanced training through a fellowship in neuromuscular medicine and earned a medical education certificate.Certified by the American Board of Psychiatry and Neurology and the American Board of Electrodiagnostic Medicine, he joined the UT Southwestern faculty in 2021. He is a member of the American Academy of Neurology, the American Academy of Neuromuscular & Electrodiagnostic Medicine, the Dallas County Medical Society, and the Texas Neurological Society.Dr. Bhai’s clinical interests include the evaluation, diagnosis, and treatment of neuromuscular disorders. He focuses on patients with inflammatory and metabolic myopathies as well as those with immune checkpoint inhibitor complications.Dr. Bhai’s research focuses on understanding how muscles communicate with other organ systems, particularly when muscle is inflamed, such as in myositis. The goal of his research is to better understand, diagnose, and treat patients with myositis through exercise and muscle physiology studies as well as through clinical trials. Among other work, he serves as the Principal Investigator for four clinical trials related to inflammatory and metabolic myopathies.

Dr. Bhai is rated as an Experienced provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are Glycogen Storage Disease Type 5, Inclusion Body Myositis, Dermatomyositis, Myositis, and Shoulder Arthroscopy.

His clinical research consists of co-authoring 35 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.